Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors

Ferry Eskens; GA Greim; Lia Zuylen; I Wolff; LJ Denis; AST Planting; FA Muskiet; J Wanders; NC Barbet; L Choi; R Capdeville; Jaap Verweij; AR Hanauske; U Bruntsch

Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors

Ferry Eskens, GA Greim, Lia Zuylen, I Wolff, LJ Denis, AST Planting, FA Muskiet, J Wanders, NC Barbet, L Choi, R Capdeville, Jaap Verweij, AR Hanauske, U Bruntsch

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1736-1743
Number of pages	8
Journal	Clinical Cancer Research
Volume	6
Publication status	Published - 2000

Cite this

Eskens, F., Greim, GA., Zuylen, L., Wolff, I., Denis, LJ., Planting, AST., Muskiet, FA., Wanders, J., Barbet, NC., Choi, L., Capdeville, R., Verweij, J., Hanauske, AR., & Bruntsch, U. (2000). Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. Clinical Cancer Research, 6, 1736-1743.

@article{abf355068a7840fda8fa449e18d9297d,

title = "Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors",

author = "Ferry Eskens and GA Greim and Lia Zuylen and I Wolff and LJ Denis and AST Planting and FA Muskiet and J Wanders and NC Barbet and L Choi and R Capdeville and Jaap Verweij and AR Hanauske and U Bruntsch",

year = "2000",

language = "Undefined/Unknown",

volume = "6",

pages = "1736--1743",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

Eskens, F, Greim, GA, Zuylen, L, Wolff, I, Denis, LJ, Planting, AST, Muskiet, FA, Wanders, J, Barbet, NC, Choi, L, Capdeville, R, Verweij, J, Hanauske, AR & Bruntsch, U 2000, 'Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors', Clinical Cancer Research, vol. 6, pp. 1736-1743.

TY - JOUR

T1 - Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors

AU - Eskens, Ferry

AU - Greim, GA

AU - Zuylen, Lia

AU - Wolff, I

AU - Denis, LJ

AU - Planting, AST

AU - Muskiet, FA

AU - Wanders, J

AU - Barbet, NC

AU - Choi, L

AU - Capdeville, R

AU - Verweij, Jaap

AU - Hanauske, AR

AU - Bruntsch, U

PY - 2000

Y1 - 2000

M3 - Article

VL - 6

SP - 1736

EP - 1743

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -